Nerviano Medical Sciences - Part of NMS Group Email Formats

Research Services • Legnano, Lombardy, Italy • 101-200 Employees

Nerviano Medical Sciences - Part of NMS Group Email Formats

Nerviano Medical Sciences - Part of NMS Group uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nervianoms.com), used 80.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@nervianoms.com	80.5%
{first initial}.{last name}	j.doe@nervianoms.com	19.5%

Key Contacts at Nerviano Medical Sciences - Part of NMS Group

Tiziano Lazzaretti

Executive Director

Davide Martin Marchetti

Statistics & Data Management Director

Cristina Davite

Director Of Clinical Operations

Barbara Mangiacavalli

Hr Director

Michele Caruso

Associate Director Of Chemistry

Francesco Colotta

R&D Director

Latini Fabio

Associate Director

Eva Tamborini

Study Director

Company overview

Headquarters	VIALE LUIGI PASTEUR 10, NERVIANO, Mi 20014, IT
Phone number	+390331581111
Website	nervianoms.com
Founded	2004
Employees	101-200
Socials

About Nerviano Medical Sciences - Part of NMS Group

Nerviano Medical Sciences S.r.l. (NMS Srl) focuses on discovering and clinically developing small molecule NCEs for oncology, aiming to deliver first- and best-in-class personalized cancer treatments through innovative mechanisms and novel drug targets. Our pipeline, built from our validated kinase platform, includes projects from early preclinical to clinical stages, advanced both internally and in partnership. NMS Srl combines biotech agility with big pharma quality, guided by an experienced management team and a skilled staff with global expertise in research, drug discovery, and clinical development. Our capabilities are extended by NMS Group affiliates Accelera (AdMet) and NerPharMa (manufacturing), covering the entire drug development process. A core strength lies in our renowned kinase inhibitor platform, featuring an extensive chemical library and IP coverage, which has led to successful out-licensing deals, including with encorafenib and entrectinib. Additionally, we are advancing a PARP-family-focused platform to discover NCEs targeting NAD-binding pockets, with potential expansion to other NAD-dependent enzymes. Our growing payload-linker platform further enhances our pipeline by enabling next-generation ADC production. Collaborating globally with academic, clinical, and industry partners, we seek further strategic alliances to develop, commercialize, and expand our product portfolio while exploring in-licensing opportunities for promising clinical assets.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Nerviano Medical Sciences - Part of NMS Group has 88 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Nerviano Medical Sciences - Part of NMS Group's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-21	11	$220,900,000

Funding Insights

$220,900,000

Total funding amount

$220,900,000

Most recent funding amount

Number of funding rounds

Nerviano Medical Sciences - Part of NMS Group Tech Stack

Discover the technologies and tools that power Nerviano Medical Sciences - Part of NMS Group's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

WP Rocket

Caching

Hello Elementor

WordPress themes

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Redis

Databases

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Google Analytics

Analytics

Redis Object Cache

Caching

Frequently asked questions

Nerviano Medical Sciences - Part of NMS Group is located in Legnano, Lombardy, IT.

You can reach Nerviano Medical Sciences - Part of NMS Group at +390331581111.

Nerviano Medical Sciences - Part of NMS Group was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

Nerviano Medical Sciences - Part of NMS Group has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Nerviano Medical Sciences - Part of NMS Group has raised a total of $220,900,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.